Lavanya Ayurvedic develops herbo-mineral ayurvedic drug Las01 to treat cancer

Lavanya Ayurvedic Private Limited that runs a successful and renowned chain of ayurvedic hospitals and cancer research centres has developed and extensively tested herbo-mineral ayurvedic drug – Las01, which makes treatment of cancer a reality.
Las01 has been used successfully for treatment of different types of cancers at Lavanya Ayurvedic Hospital and Cancer Research Centre, Lucknow. The breast cancer and cervical cancer cell lines procured from National Centre of Cell Science, Pune, were used for the marker test of proliferation and apoptosis (programmed cell death).
According to Ashok Srivastava, chairman, Lavanya Ayurveda, “So far 36,000 cancer patients from all over India and abroad have registered with us and have received treatment for various forms of cancer at our modern and state-of-the-art hospitals. Of this almost 80 per cent had lost all hope. Some of the biggest hospitals had given up on them. We have been able to manage some of the most difficult cases and around 70 per cent of them have been successfully treated. They are back to their functional life. Their medical condition had worsened even after receiving chemotherapy and radiation from other sources earlier. This is primarily because chemotherapy and radiation only stop proliferation (multiplication) of cancerous cells temporarily through suppression, affecting the good cells as well. As and when their effect ends, the proliferation of cancerous cells starts all over again. Las01, our herbo-mineral Ayurvedic drug eliminates the root cause of cancer within the cells.”
Las01 has stopped proliferation up to 78 per cent and increases apoptosis up to 57 per cent in breast as well as cervical cell lines. It converts unregulated undesirable immortal cancer cells into desirable well regulated apoptotic cells. This novel preparation of Las01 is also found to be devoid of any toxicity whatsoever both in animals as well as in human subjects, which happens to be the main drawback of chemotherapeutic agents used in modern system of medicine. There was no significant change of WBC count, haemoglobin content, differential counts and hepatic and renal function during the acute and chronic administration of Las01 up to 14 and 90 days respectively. Acute and chronic administration of these drugs did not produce any alteration in sodium, potassium, chloride and bicarbonate levels. No remarkable histopathological changes were noted in the internal organs of animal subjects receiving these drugs in higher doses.
“Yuvraj Singh, the renowned cricketer, reportedly suffering from lung tumour is in news these days and leading doctors have been offering opinions in national media about the time in which he shall be able to make a comeback. We have been treating lung cancer day in day out and many more complex cases are now leading perfectly healthy lives,” adds Srivastava.
Recently six different research papers from Lavanya Ayurveda Hospitals which were selected for presentation in the national seminar on management of cancer through Ayurveda conducted by Rashtriya Ayurved Vidyapeeth. Top scientists, Ayurveda experts, research centres, hospitals and institutions from across the country participated in the same and presented their research papers.
Source:Pharmabiz